Annual Total Liabilities
$154.14 M
+$10.63 M+7.40%
December 31, 2023
Summary
- As of February 8, 2025, MRNS annual total liabilities is $154.14 million, with the most recent change of +$10.63 million (+7.40%) on December 31, 2023.
- During the last 3 years, MRNS annual total liabilities has risen by +$140.88 million (+1062.20%).
- MRNS annual total liabilities is now at all-time high.
Performance
MRNS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$130.36 M
-$4.06 M-3.02%
September 30, 2024
Summary
- As of February 8, 2025, MRNS quarterly total liabilities is $130.36 million, with the most recent change of -$4.06 million (-3.02%) on September 30, 2024.
- Over the past year, MRNS quarterly total liabilities has stayed the same.
- MRNS quarterly total liabilities is now -15.43% below its all-time high of $154.14 million, reached on December 31, 2023.
Performance
MRNS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MRNS Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +7.4% | 0.0% |
3 y3 years | +1062.2% | -9.2% |
5 y5 years | +2131.1% | -9.2% |
MRNS Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +84.9% | -15.4% | +56.4% |
5 y | 5-year | at high | +1292.1% | -15.4% | +1077.3% |
alltime | all time | at high | +6414.9% | -15.4% | +6732.5% |
Marinus Pharmaceuticals Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $130.36 M(-3.0%) |
Jun 2024 | - | $134.43 M(-12.6%) |
Mar 2024 | - | $153.78 M(-0.2%) |
Dec 2023 | $154.14 M(+7.4%) | $154.14 M(+5.4%) |
Sep 2023 | - | $146.27 M(+1.7%) |
Jun 2023 | - | $143.86 M(+1.5%) |
Mar 2023 | - | $141.73 M(-1.2%) |
Dec 2022 | $143.52 M(+72.2%) | $143.52 M(+39.6%) |
Sep 2022 | - | $102.84 M(-1.7%) |
Jun 2022 | - | $104.57 M(+4.2%) |
Mar 2022 | - | $100.41 M(+20.5%) |
Dec 2021 | $83.35 M(+528.5%) | $83.35 M(+3.7%) |
Sep 2021 | - | $80.38 M(+168.6%) |
Jun 2021 | - | $29.93 M(+61.6%) |
Mar 2021 | - | $18.52 M(+39.7%) |
Dec 2020 | $13.26 M(+19.8%) | $13.26 M(+9.6%) |
Sep 2020 | - | $12.10 M(-1.6%) |
Jun 2020 | - | $12.30 M(-7.1%) |
Mar 2020 | - | $13.24 M(+19.6%) |
Dec 2019 | $11.07 M | $11.07 M(-5.6%) |
Sep 2019 | - | $11.73 M(-5.3%) |
Jun 2019 | - | $12.38 M(+25.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $9.87 M(+42.9%) |
Dec 2018 | $6.91 M(+159.3%) | $6.91 M(-1.0%) |
Sep 2018 | - | $6.98 M(+90.3%) |
Jun 2018 | - | $3.67 M(+92.2%) |
Mar 2018 | - | $1.91 M(-28.4%) |
Dec 2017 | $2.66 M(-73.3%) | $2.66 M(+4.2%) |
Sep 2017 | - | $2.56 M(-56.0%) |
Jun 2017 | - | $5.81 M(-23.4%) |
Mar 2017 | - | $7.58 M(-24.0%) |
Dec 2016 | $9.97 M(-21.7%) | $9.97 M(-16.5%) |
Sep 2016 | - | $11.94 M(-13.7%) |
Jun 2016 | - | $13.83 M(+13.2%) |
Mar 2016 | - | $12.22 M(-4.0%) |
Dec 2015 | $12.73 M(+40.5%) | $12.73 M(+14.7%) |
Sep 2015 | - | $11.10 M(-0.5%) |
Jun 2015 | - | $11.16 M(-4.0%) |
Mar 2015 | - | $11.62 M(+28.3%) |
Dec 2014 | $9.06 M(+282.9%) | $9.06 M(+171.6%) |
Sep 2014 | - | $3.34 M(-33.3%) |
Jun 2014 | - | $5.00 M(+146.9%) |
Mar 2014 | - | $2.03 M(-14.4%) |
Dec 2013 | $2.37 M(-47.4%) | $2.37 M |
Dec 2012 | $4.50 M | - |
FAQ
- What is Marinus Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals annual total liabilities year-on-year change?
- What is Marinus Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals quarterly total liabilities year-on-year change?
What is Marinus Pharmaceuticals annual total liabilities?
The current annual total liabilities of MRNS is $154.14 M
What is the all time high annual total liabilities for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high annual total liabilities is $154.14 M
What is Marinus Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, MRNS annual total liabilities has changed by +$10.63 M (+7.40%)
What is Marinus Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of MRNS is $130.36 M
What is the all time high quarterly total liabilities for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high quarterly total liabilities is $154.14 M
What is Marinus Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, MRNS quarterly total liabilities has changed by $0.00 (0.00%)